nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—MPO—Carboplatin—brain cancer	0.375	0.497	CbGbCtD
Nabumetone—CYP1A2—Carmustine—brain cancer	0.138	0.183	CbGbCtD
Nabumetone—PTGS2—Etoposide—brain cancer	0.109	0.144	CbGbCtD
Nabumetone—PTGS1—Etoposide—brain cancer	0.0917	0.122	CbGbCtD
Nabumetone—CYP1A2—Etoposide—brain cancer	0.041	0.0543	CbGbCtD
Nabumetone—Agomelatine—CYP2C9—brain cancer	0.00289	0.441	CrCbGaD
Nabumetone—MPO—endothelium—brain cancer	0.00236	0.118	CbGeAlD
Nabumetone—MPO—blood vessel—brain cancer	0.00218	0.108	CbGeAlD
Nabumetone—Naproxen—CYP2C9—brain cancer	0.00197	0.3	CrCbGaD
Nabumetone—PTGS1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00179	0.0758	CbGpPWpGaD
Nabumetone—Melatonin—CYP2C9—brain cancer	0.00169	0.258	CrCbGaD
Nabumetone—PTGS2—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00142	0.0602	CbGpPWpGaD
Nabumetone—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00133	0.0563	CbGpPWpGaD
Nabumetone—PTGS1—ganglion—brain cancer	0.0013	0.0647	CbGeAlD
Nabumetone—PTGS1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.00124	0.0525	CbGpPWpGaD
Nabumetone—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00121	0.0512	CbGpPWpGaD
Nabumetone—Abnormal vision—Carmustine—brain cancer	0.00114	0.00586	CcSEcCtD
Nabumetone—Stomatitis—Procarbazine—brain cancer	0.00114	0.00585	CcSEcCtD
Nabumetone—Jaundice—Procarbazine—brain cancer	0.00114	0.00585	CcSEcCtD
Nabumetone—Anorexia—Lomustine—brain cancer	0.00112	0.00575	CcSEcCtD
Nabumetone—PTGS1—endothelium—brain cancer	0.00112	0.0558	CbGeAlD
Nabumetone—Haematuria—Procarbazine—brain cancer	0.00112	0.00572	CcSEcCtD
Nabumetone—Abnormal vision—Temozolomide—brain cancer	0.00111	0.00566	CcSEcCtD
Nabumetone—Thrombophlebitis—Carmustine—brain cancer	0.0011	0.00563	CcSEcCtD
Nabumetone—Hyperuricaemia—Etoposide—brain cancer	0.00109	0.0056	CcSEcCtD
Nabumetone—PTGS2—endothelium—brain cancer	0.00107	0.0533	CbGeAlD
Nabumetone—Body temperature increased—Carboplatin—brain cancer	0.00106	0.00545	CcSEcCtD
Nabumetone—Thrombophlebitis—Temozolomide—brain cancer	0.00106	0.00544	CcSEcCtD
Nabumetone—Haemoglobin—Procarbazine—brain cancer	0.00106	0.00542	CcSEcCtD
Nabumetone—Haemorrhage—Procarbazine—brain cancer	0.00105	0.00539	CcSEcCtD
Nabumetone—Gastroenteritis—Temozolomide—brain cancer	0.00104	0.00531	CcSEcCtD
Nabumetone—PTGS1—blood vessel—brain cancer	0.00103	0.0514	CbGeAlD
Nabumetone—Blood uric acid increased—Etoposide—brain cancer	0.00103	0.00529	CcSEcCtD
Nabumetone—Decreased appetite—Lomustine—brain cancer	0.00102	0.00524	CcSEcCtD
Nabumetone—Hepatic failure—Temozolomide—brain cancer	0.00102	0.00524	CcSEcCtD
Nabumetone—Pancreatitis—Hydroxyurea—brain cancer	0.000998	0.00511	CcSEcCtD
Nabumetone—PTGS2—blood vessel—brain cancer	0.000988	0.0491	CbGeAlD
Nabumetone—PTGS2—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.000983	0.0417	CbGpPWpGaD
Nabumetone—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.000952	0.00487	CcSEcCtD
Nabumetone—Dysuria—Hydroxyurea—brain cancer	0.000952	0.00487	CcSEcCtD
Nabumetone—Chills—Procarbazine—brain cancer	0.000945	0.00484	CcSEcCtD
Nabumetone—Arrhythmia—Procarbazine—brain cancer	0.000941	0.00481	CcSEcCtD
Nabumetone—Body temperature increased—Lomustine—brain cancer	0.000932	0.00477	CcSEcCtD
Nabumetone—Alopecia—Procarbazine—brain cancer	0.000931	0.00476	CcSEcCtD
Nabumetone—Weight increased—Hydroxyurea—brain cancer	0.000927	0.00474	CcSEcCtD
Nabumetone—Tension—Procarbazine—brain cancer	0.0009	0.0046	CcSEcCtD
Nabumetone—Nervousness—Procarbazine—brain cancer	0.00089	0.00456	CcSEcCtD
Nabumetone—Stomatitis—Hydroxyurea—brain cancer	0.000885	0.00453	CcSEcCtD
Nabumetone—Liver function test abnormal—Carmustine—brain cancer	0.000879	0.0045	CcSEcCtD
Nabumetone—Hypokalaemia—Carmustine—brain cancer	0.000867	0.00444	CcSEcCtD
Nabumetone—MPO—pituitary gland—brain cancer	0.000861	0.0428	CbGeAlD
Nabumetone—Tremor—Procarbazine—brain cancer	0.000859	0.0044	CcSEcCtD
Nabumetone—Anaemia—Procarbazine—brain cancer	0.000847	0.00434	CcSEcCtD
Nabumetone—Hypokalaemia—Temozolomide—brain cancer	0.000838	0.00429	CcSEcCtD
Nabumetone—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000829	0.00424	CcSEcCtD
Nabumetone—Dysphagia—Carmustine—brain cancer	0.000823	0.00421	CcSEcCtD
Nabumetone—Syncope—Procarbazine—brain cancer	0.000822	0.00421	CcSEcCtD
Nabumetone—Leukopenia—Procarbazine—brain cancer	0.000821	0.0042	CcSEcCtD
Nabumetone—Haemoglobin—Hydroxyurea—brain cancer	0.000819	0.00419	CcSEcCtD
Nabumetone—Haemorrhage—Hydroxyurea—brain cancer	0.000815	0.00417	CcSEcCtD
Nabumetone—Loss of consciousness—Procarbazine—brain cancer	0.000806	0.00412	CcSEcCtD
Nabumetone—Cough—Procarbazine—brain cancer	0.0008	0.00409	CcSEcCtD
Nabumetone—Dysphagia—Temozolomide—brain cancer	0.000795	0.00407	CcSEcCtD
Nabumetone—Hypertension—Procarbazine—brain cancer	0.000791	0.00405	CcSEcCtD
Nabumetone—Anxiety—Procarbazine—brain cancer	0.000778	0.00398	CcSEcCtD
Nabumetone—Sweating increased—Temozolomide—brain cancer	0.000775	0.00397	CcSEcCtD
Nabumetone—Dry mouth—Procarbazine—brain cancer	0.000763	0.00391	CcSEcCtD
Nabumetone—Anaphylactoid reaction—Etoposide—brain cancer	0.000761	0.00389	CcSEcCtD
Nabumetone—Confusional state—Procarbazine—brain cancer	0.000754	0.00386	CcSEcCtD
Nabumetone—Vomiting—Lomustine—brain cancer	0.000749	0.00383	CcSEcCtD
Nabumetone—Oedema—Procarbazine—brain cancer	0.000748	0.00383	CcSEcCtD
Nabumetone—Dysuria—Temozolomide—brain cancer	0.000744	0.00381	CcSEcCtD
Nabumetone—Hyperglycaemia—Carmustine—brain cancer	0.000743	0.0038	CcSEcCtD
Nabumetone—MPO—spinal cord—brain cancer	0.000741	0.0368	CbGeAlD
Nabumetone—Pneumonia—Carmustine—brain cancer	0.000738	0.00378	CcSEcCtD
Nabumetone—Shock—Procarbazine—brain cancer	0.000736	0.00377	CcSEcCtD
Nabumetone—Erectile dysfunction—Temozolomide—brain cancer	0.000733	0.00375	CcSEcCtD
Nabumetone—Thrombocytopenia—Procarbazine—brain cancer	0.000733	0.00375	CcSEcCtD
Nabumetone—Depression—Carmustine—brain cancer	0.000732	0.00375	CcSEcCtD
Nabumetone—Chills—Hydroxyurea—brain cancer	0.000731	0.00374	CcSEcCtD
Nabumetone—Photosensitivity reaction—Temozolomide—brain cancer	0.000726	0.00372	CcSEcCtD
Nabumetone—Weight increased—Temozolomide—brain cancer	0.000724	0.0037	CcSEcCtD
Nabumetone—Hyperhidrosis—Procarbazine—brain cancer	0.000723	0.0037	CcSEcCtD
Nabumetone—Renal failure—Carmustine—brain cancer	0.000721	0.00369	CcSEcCtD
Nabumetone—Alopecia—Hydroxyurea—brain cancer	0.00072	0.00369	CcSEcCtD
Nabumetone—Weight decreased—Temozolomide—brain cancer	0.00072	0.00368	CcSEcCtD
Nabumetone—Hyperglycaemia—Temozolomide—brain cancer	0.000718	0.00367	CcSEcCtD
Nabumetone—Stomatitis—Carmustine—brain cancer	0.000715	0.00366	CcSEcCtD
Nabumetone—Pneumonia—Temozolomide—brain cancer	0.000713	0.00365	CcSEcCtD
Nabumetone—Anorexia—Procarbazine—brain cancer	0.000713	0.00365	CcSEcCtD
Nabumetone—Depression—Temozolomide—brain cancer	0.000707	0.00362	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000703	0.0036	CcSEcCtD
Nabumetone—Nausea—Lomustine—brain cancer	0.0007	0.00358	CcSEcCtD
Nabumetone—Stomatitis—Temozolomide—brain cancer	0.000691	0.00354	CcSEcCtD
Nabumetone—PTGS1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000682	0.0289	CbGpPWpGaD
Nabumetone—Insomnia—Procarbazine—brain cancer	0.000677	0.00346	CcSEcCtD
Nabumetone—Paraesthesia—Procarbazine—brain cancer	0.000672	0.00344	CcSEcCtD
Nabumetone—MPO—endocrine gland—brain cancer	0.000667	0.0332	CbGeAlD
Nabumetone—Somnolence—Procarbazine—brain cancer	0.000665	0.0034	CcSEcCtD
Nabumetone—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000663	0.00339	CcSEcCtD
Nabumetone—Haemoglobin—Carmustine—brain cancer	0.000662	0.00339	CcSEcCtD
Nabumetone—Haemorrhage—Carmustine—brain cancer	0.000659	0.00337	CcSEcCtD
Nabumetone—MPO—head—brain cancer	0.000658	0.0327	CbGeAlD
Nabumetone—Ill-defined disorder—Hydroxyurea—brain cancer	0.000658	0.00337	CcSEcCtD
Nabumetone—Anaemia—Hydroxyurea—brain cancer	0.000656	0.00336	CcSEcCtD
Nabumetone—Decreased appetite—Procarbazine—brain cancer	0.00065	0.00333	CcSEcCtD
Nabumetone—Fatigue—Procarbazine—brain cancer	0.000645	0.0033	CcSEcCtD
Nabumetone—Haemoglobin—Temozolomide—brain cancer	0.00064	0.00328	CcSEcCtD
Nabumetone—Malaise—Hydroxyurea—brain cancer	0.00064	0.00327	CcSEcCtD
Nabumetone—Constipation—Procarbazine—brain cancer	0.00064	0.00327	CcSEcCtD
Nabumetone—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000638	0.027	CbGpPWpGaD
Nabumetone—Haemorrhage—Temozolomide—brain cancer	0.000637	0.00326	CcSEcCtD
Nabumetone—Dysphagia—Etoposide—brain cancer	0.000637	0.00326	CcSEcCtD
Nabumetone—Leukopenia—Hydroxyurea—brain cancer	0.000635	0.00325	CcSEcCtD
Nabumetone—Visual impairment—Carmustine—brain cancer	0.000635	0.00325	CcSEcCtD
Nabumetone—Sweating increased—Etoposide—brain cancer	0.00062	0.00317	CcSEcCtD
Nabumetone—Feeling abnormal—Procarbazine—brain cancer	0.000617	0.00316	CcSEcCtD
Nabumetone—Visual impairment—Temozolomide—brain cancer	0.000614	0.00314	CcSEcCtD
Nabumetone—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000613	0.026	CbGpPWpGaD
Nabumetone—Gastrointestinal pain—Procarbazine—brain cancer	0.000612	0.00313	CcSEcCtD
Nabumetone—Erythema multiforme—Temozolomide—brain cancer	0.000602	0.00308	CcSEcCtD
Nabumetone—MPO—central nervous system—brain cancer	0.000601	0.0299	CbGeAlD
Nabumetone—Discomfort—Hydroxyurea—brain cancer	0.000597	0.00305	CcSEcCtD
Nabumetone—Urticaria—Procarbazine—brain cancer	0.000594	0.00304	CcSEcCtD
Nabumetone—Tinnitus—Temozolomide—brain cancer	0.000594	0.00304	CcSEcCtD
Nabumetone—Body temperature increased—Procarbazine—brain cancer	0.000591	0.00303	CcSEcCtD
Nabumetone—Abdominal pain—Procarbazine—brain cancer	0.000591	0.00303	CcSEcCtD
Nabumetone—Arrhythmia—Carmustine—brain cancer	0.000589	0.00301	CcSEcCtD
Nabumetone—MPO—Vitamin B12 Metabolism—SOD2—brain cancer	0.000588	0.0249	CbGpPWpGaD
Nabumetone—Alopecia—Carmustine—brain cancer	0.000582	0.00298	CcSEcCtD
Nabumetone—Oedema—Hydroxyurea—brain cancer	0.000579	0.00296	CcSEcCtD
Nabumetone—Chills—Temozolomide—brain cancer	0.000571	0.00292	CcSEcCtD
Nabumetone—Pneumonia—Etoposide—brain cancer	0.000571	0.00292	CcSEcCtD
Nabumetone—Thrombocytopenia—Hydroxyurea—brain cancer	0.000567	0.0029	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000563	0.00288	CcSEcCtD
Nabumetone—Alopecia—Temozolomide—brain cancer	0.000563	0.00288	CcSEcCtD
Nabumetone—Acute coronary syndrome—Etoposide—brain cancer	0.000559	0.00286	CcSEcCtD
Nabumetone—Renal failure—Etoposide—brain cancer	0.000558	0.00286	CcSEcCtD
Nabumetone—Myocardial infarction—Etoposide—brain cancer	0.000556	0.00285	CcSEcCtD
Nabumetone—Jaundice—Etoposide—brain cancer	0.000553	0.00283	CcSEcCtD
Nabumetone—Stomatitis—Etoposide—brain cancer	0.000553	0.00283	CcSEcCtD
Nabumetone—Anorexia—Hydroxyurea—brain cancer	0.000552	0.00282	CcSEcCtD
Nabumetone—Hypersensitivity—Procarbazine—brain cancer	0.000551	0.00282	CcSEcCtD
Nabumetone—PTGS2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000541	0.023	CbGpPWpGaD
Nabumetone—Tremor—Carmustine—brain cancer	0.000537	0.00275	CcSEcCtD
Nabumetone—MPO—C-MYB transcription factor network—CDK6—brain cancer	0.000537	0.0228	CbGpPWpGaD
Nabumetone—Asthenia—Procarbazine—brain cancer	0.000537	0.00275	CcSEcCtD
Nabumetone—Anaemia—Carmustine—brain cancer	0.00053	0.00271	CcSEcCtD
Nabumetone—Agranulocytosis—Etoposide—brain cancer	0.00053	0.00271	CcSEcCtD
Nabumetone—Pruritus—Procarbazine—brain cancer	0.000529	0.00271	CcSEcCtD
Nabumetone—Agitation—Carmustine—brain cancer	0.000527	0.0027	CcSEcCtD
Nabumetone—Tremor—Temozolomide—brain cancer	0.000519	0.00266	CcSEcCtD
Nabumetone—Dyspnoea—Hydroxyurea—brain cancer	0.000516	0.00264	CcSEcCtD
Nabumetone—Somnolence—Hydroxyurea—brain cancer	0.000515	0.00263	CcSEcCtD
Nabumetone—Ill-defined disorder—Temozolomide—brain cancer	0.000514	0.00263	CcSEcCtD
Nabumetone—Leukopenia—Carmustine—brain cancer	0.000513	0.00263	CcSEcCtD
Nabumetone—Anaemia—Temozolomide—brain cancer	0.000512	0.00262	CcSEcCtD
Nabumetone—Diarrhoea—Procarbazine—brain cancer	0.000512	0.00262	CcSEcCtD
Nabumetone—Dyspepsia—Hydroxyurea—brain cancer	0.00051	0.00261	CcSEcCtD
Nabumetone—Agitation—Temozolomide—brain cancer	0.000509	0.00261	CcSEcCtD
Nabumetone—Angioedema—Temozolomide—brain cancer	0.000506	0.00259	CcSEcCtD
Nabumetone—Decreased appetite—Hydroxyurea—brain cancer	0.000503	0.00258	CcSEcCtD
Nabumetone—PTGS1—telencephalon—brain cancer	0.000502	0.0249	CbGeAlD
Nabumetone—Malaise—Temozolomide—brain cancer	0.0005	0.00256	CcSEcCtD
Nabumetone—Fatigue—Hydroxyurea—brain cancer	0.000499	0.00255	CcSEcCtD
Nabumetone—Vertigo—Temozolomide—brain cancer	0.000498	0.00255	CcSEcCtD
Nabumetone—Leukopenia—Temozolomide—brain cancer	0.000496	0.00254	CcSEcCtD
Nabumetone—Hypertension—Carmustine—brain cancer	0.000495	0.00253	CcSEcCtD
Nabumetone—Constipation—Hydroxyurea—brain cancer	0.000495	0.00253	CcSEcCtD
Nabumetone—Dizziness—Procarbazine—brain cancer	0.000495	0.00253	CcSEcCtD
Nabumetone—Palpitations—Temozolomide—brain cancer	0.00049	0.00251	CcSEcCtD
Nabumetone—Anxiety—Carmustine—brain cancer	0.000487	0.00249	CcSEcCtD
Nabumetone—Cough—Temozolomide—brain cancer	0.000484	0.00248	CcSEcCtD
Nabumetone—Erythema multiforme—Etoposide—brain cancer	0.000482	0.00247	CcSEcCtD
Nabumetone—PTGS2—telencephalon—brain cancer	0.000479	0.0238	CbGeAlD
Nabumetone—Hypertension—Temozolomide—brain cancer	0.000479	0.00245	CcSEcCtD
Nabumetone—MPO—Folate Metabolism—SOD2—brain cancer	0.000478	0.0203	CbGpPWpGaD
Nabumetone—PTGS1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000478	0.0203	CbGpPWpGaD
Nabumetone—Feeling abnormal—Hydroxyurea—brain cancer	0.000477	0.00244	CcSEcCtD
Nabumetone—MPO—brain—brain cancer	0.000477	0.0237	CbGeAlD
Nabumetone—Vomiting—Procarbazine—brain cancer	0.000476	0.00243	CcSEcCtD
Nabumetone—Confusional state—Carmustine—brain cancer	0.000472	0.00242	CcSEcCtD
Nabumetone—Rash—Procarbazine—brain cancer	0.000472	0.00241	CcSEcCtD
Nabumetone—Dermatitis—Procarbazine—brain cancer	0.000471	0.00241	CcSEcCtD
Nabumetone—Anxiety—Temozolomide—brain cancer	0.00047	0.00241	CcSEcCtD
Nabumetone—Headache—Procarbazine—brain cancer	0.000469	0.0024	CcSEcCtD
Nabumetone—Oedema—Carmustine—brain cancer	0.000468	0.0024	CcSEcCtD
Nabumetone—Discomfort—Temozolomide—brain cancer	0.000466	0.00239	CcSEcCtD
Nabumetone—Dry mouth—Temozolomide—brain cancer	0.000462	0.00236	CcSEcCtD
Nabumetone—Thrombocytopenia—Carmustine—brain cancer	0.000458	0.00235	CcSEcCtD
Nabumetone—Body temperature increased—Hydroxyurea—brain cancer	0.000458	0.00234	CcSEcCtD
Nabumetone—Chills—Etoposide—brain cancer	0.000457	0.00234	CcSEcCtD
Nabumetone—Confusional state—Temozolomide—brain cancer	0.000456	0.00233	CcSEcCtD
Nabumetone—Anaphylactic shock—Temozolomide—brain cancer	0.000452	0.00232	CcSEcCtD
Nabumetone—Oedema—Temozolomide—brain cancer	0.000452	0.00232	CcSEcCtD
Nabumetone—Alopecia—Etoposide—brain cancer	0.00045	0.0023	CcSEcCtD
Nabumetone—Anorexia—Carmustine—brain cancer	0.000446	0.00228	CcSEcCtD
Nabumetone—Nausea—Procarbazine—brain cancer	0.000444	0.00227	CcSEcCtD
Nabumetone—Thrombocytopenia—Temozolomide—brain cancer	0.000443	0.00227	CcSEcCtD
Nabumetone—MPO—IL23-mediated signaling events—RELA—brain cancer	0.000439	0.0186	CbGpPWpGaD
Nabumetone—Hyperhidrosis—Temozolomide—brain cancer	0.000437	0.00224	CcSEcCtD
Nabumetone—Anorexia—Temozolomide—brain cancer	0.000431	0.00221	CcSEcCtD
Nabumetone—Hypersensitivity—Hydroxyurea—brain cancer	0.000427	0.00218	CcSEcCtD
Nabumetone—Insomnia—Carmustine—brain cancer	0.000423	0.00217	CcSEcCtD
Nabumetone—Paraesthesia—Carmustine—brain cancer	0.00042	0.00215	CcSEcCtD
Nabumetone—Dyspnoea—Carmustine—brain cancer	0.000417	0.00214	CcSEcCtD
Nabumetone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000417	0.0177	CbGpPWpGaD
Nabumetone—Somnolence—Carmustine—brain cancer	0.000416	0.00213	CcSEcCtD
Nabumetone—Asthenia—Hydroxyurea—brain cancer	0.000415	0.00213	CcSEcCtD
Nabumetone—Ill-defined disorder—Etoposide—brain cancer	0.000412	0.00211	CcSEcCtD
Nabumetone—Anaemia—Etoposide—brain cancer	0.00041	0.0021	CcSEcCtD
Nabumetone—Insomnia—Temozolomide—brain cancer	0.000409	0.00209	CcSEcCtD
Nabumetone—PTGS1—pituitary gland—brain cancer	0.000408	0.0203	CbGeAlD
Nabumetone—Decreased appetite—Carmustine—brain cancer	0.000407	0.00208	CcSEcCtD
Nabumetone—Paraesthesia—Temozolomide—brain cancer	0.000406	0.00208	CcSEcCtD
Nabumetone—Dyspnoea—Temozolomide—brain cancer	0.000403	0.00206	CcSEcCtD
Nabumetone—Somnolence—Temozolomide—brain cancer	0.000402	0.00206	CcSEcCtD
Nabumetone—Constipation—Carmustine—brain cancer	0.0004	0.00205	CcSEcCtD
Nabumetone—Malaise—Etoposide—brain cancer	0.0004	0.00205	CcSEcCtD
Nabumetone—Vertigo—Etoposide—brain cancer	0.000398	0.00204	CcSEcCtD
Nabumetone—Dyspepsia—Temozolomide—brain cancer	0.000398	0.00204	CcSEcCtD
Nabumetone—Leukopenia—Etoposide—brain cancer	0.000397	0.00203	CcSEcCtD
Nabumetone—Diarrhoea—Hydroxyurea—brain cancer	0.000396	0.00203	CcSEcCtD
Nabumetone—MPO—IL23-mediated signaling events—IL2—brain cancer	0.000396	0.0168	CbGpPWpGaD
Nabumetone—MPO—C-MYB transcription factor network—HES1—brain cancer	0.000395	0.0168	CbGpPWpGaD
Nabumetone—Decreased appetite—Temozolomide—brain cancer	0.000393	0.00201	CcSEcCtD
Nabumetone—PTGS2—pituitary gland—brain cancer	0.00039	0.0194	CbGeAlD
Nabumetone—Fatigue—Temozolomide—brain cancer	0.00039	0.002	CcSEcCtD
Nabumetone—Loss of consciousness—Etoposide—brain cancer	0.00039	0.00199	CcSEcCtD
Nabumetone—Cough—Etoposide—brain cancer	0.000387	0.00198	CcSEcCtD
Nabumetone—Constipation—Temozolomide—brain cancer	0.000387	0.00198	CcSEcCtD
Nabumetone—Feeling abnormal—Carmustine—brain cancer	0.000386	0.00197	CcSEcCtD
Nabumetone—Hypertension—Etoposide—brain cancer	0.000383	0.00196	CcSEcCtD
Nabumetone—Dizziness—Hydroxyurea—brain cancer	0.000383	0.00196	CcSEcCtD
Nabumetone—Gastrointestinal pain—Carmustine—brain cancer	0.000383	0.00196	CcSEcCtD
Nabumetone—MPO—Selenium Micronutrient Network—SOD2—brain cancer	0.00038	0.0161	CbGpPWpGaD
Nabumetone—PTGS2—medulla oblongata—brain cancer	0.000377	0.0187	CbGeAlD
Nabumetone—Discomfort—Etoposide—brain cancer	0.000373	0.00191	CcSEcCtD
Nabumetone—Feeling abnormal—Temozolomide—brain cancer	0.000373	0.00191	CcSEcCtD
Nabumetone—Body temperature increased—Carmustine—brain cancer	0.00037	0.00189	CcSEcCtD
Nabumetone—Abdominal pain—Carmustine—brain cancer	0.00037	0.00189	CcSEcCtD
Nabumetone—Gastrointestinal pain—Temozolomide—brain cancer	0.00037	0.00189	CcSEcCtD
Nabumetone—Vomiting—Hydroxyurea—brain cancer	0.000368	0.00188	CcSEcCtD
Nabumetone—Rash—Hydroxyurea—brain cancer	0.000365	0.00187	CcSEcCtD
Nabumetone—CYP1A2—endocrine gland—brain cancer	0.000365	0.0182	CbGeAlD
Nabumetone—Confusional state—Etoposide—brain cancer	0.000365	0.00187	CcSEcCtD
Nabumetone—Dermatitis—Hydroxyurea—brain cancer	0.000365	0.00187	CcSEcCtD
Nabumetone—Headache—Hydroxyurea—brain cancer	0.000363	0.00186	CcSEcCtD
Nabumetone—Anaphylactic shock—Etoposide—brain cancer	0.000362	0.00185	CcSEcCtD
Nabumetone—Urticaria—Temozolomide—brain cancer	0.000359	0.00184	CcSEcCtD
Nabumetone—Abdominal pain—Temozolomide—brain cancer	0.000358	0.00183	CcSEcCtD
Nabumetone—Body temperature increased—Temozolomide—brain cancer	0.000358	0.00183	CcSEcCtD
Nabumetone—Thrombocytopenia—Etoposide—brain cancer	0.000354	0.00181	CcSEcCtD
Nabumetone—PTGS1—spinal cord—brain cancer	0.000351	0.0175	CbGeAlD
Nabumetone—Hyperhidrosis—Etoposide—brain cancer	0.00035	0.00179	CcSEcCtD
Nabumetone—Anorexia—Etoposide—brain cancer	0.000345	0.00177	CcSEcCtD
Nabumetone—Hypersensitivity—Carmustine—brain cancer	0.000345	0.00176	CcSEcCtD
Nabumetone—PTGS2—midbrain—brain cancer	0.000344	0.0171	CbGeAlD
Nabumetone—Nausea—Hydroxyurea—brain cancer	0.000344	0.00176	CcSEcCtD
Nabumetone—MPO—Vitamin B12 Metabolism—RELA—brain cancer	0.00034	0.0144	CbGpPWpGaD
Nabumetone—PTGS2—spinal cord—brain cancer	0.000336	0.0167	CbGeAlD
Nabumetone—Asthenia—Carmustine—brain cancer	0.000336	0.00172	CcSEcCtD
Nabumetone—Hypersensitivity—Temozolomide—brain cancer	0.000333	0.00171	CcSEcCtD
Nabumetone—MPO—IL23-mediated signaling events—STAT3—brain cancer	0.000333	0.0141	CbGpPWpGaD
Nabumetone—Paraesthesia—Etoposide—brain cancer	0.000325	0.00166	CcSEcCtD
Nabumetone—Asthenia—Temozolomide—brain cancer	0.000325	0.00166	CcSEcCtD
Nabumetone—Dyspnoea—Etoposide—brain cancer	0.000323	0.00165	CcSEcCtD
Nabumetone—Somnolence—Etoposide—brain cancer	0.000322	0.00165	CcSEcCtD
Nabumetone—Diarrhoea—Carmustine—brain cancer	0.00032	0.00164	CcSEcCtD
Nabumetone—Pruritus—Temozolomide—brain cancer	0.00032	0.00164	CcSEcCtD
Nabumetone—PTGS1—endocrine gland—brain cancer	0.000316	0.0157	CbGeAlD
Nabumetone—Decreased appetite—Etoposide—brain cancer	0.000315	0.00161	CcSEcCtD
Nabumetone—PTGS1—head—brain cancer	0.000312	0.0155	CbGeAlD
Nabumetone—Fatigue—Etoposide—brain cancer	0.000312	0.0016	CcSEcCtD
Nabumetone—Dizziness—Carmustine—brain cancer	0.00031	0.00158	CcSEcCtD
Nabumetone—Constipation—Etoposide—brain cancer	0.00031	0.00158	CcSEcCtD
Nabumetone—Diarrhoea—Temozolomide—brain cancer	0.00031	0.00158	CcSEcCtD
Nabumetone—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000306	0.013	CbGpPWpGaD
Nabumetone—PTGS2—endocrine gland—brain cancer	0.000302	0.015	CbGeAlD
Nabumetone—Dizziness—Temozolomide—brain cancer	0.000299	0.00153	CcSEcCtD
Nabumetone—PTGS2—head—brain cancer	0.000299	0.0148	CbGeAlD
Nabumetone—Feeling abnormal—Etoposide—brain cancer	0.000298	0.00153	CcSEcCtD
Nabumetone—Vomiting—Carmustine—brain cancer	0.000298	0.00152	CcSEcCtD
Nabumetone—Gastrointestinal pain—Etoposide—brain cancer	0.000296	0.00151	CcSEcCtD
Nabumetone—Rash—Carmustine—brain cancer	0.000295	0.00151	CcSEcCtD
Nabumetone—Dermatitis—Carmustine—brain cancer	0.000295	0.00151	CcSEcCtD
Nabumetone—Headache—Carmustine—brain cancer	0.000293	0.0015	CcSEcCtD
Nabumetone—Vomiting—Temozolomide—brain cancer	0.000288	0.00147	CcSEcCtD
Nabumetone—Urticaria—Etoposide—brain cancer	0.000288	0.00147	CcSEcCtD
Nabumetone—Abdominal pain—Etoposide—brain cancer	0.000286	0.00146	CcSEcCtD
Nabumetone—Body temperature increased—Etoposide—brain cancer	0.000286	0.00146	CcSEcCtD
Nabumetone—Rash—Temozolomide—brain cancer	0.000285	0.00146	CcSEcCtD
Nabumetone—PTGS1—central nervous system—brain cancer	0.000285	0.0142	CbGeAlD
Nabumetone—Dermatitis—Temozolomide—brain cancer	0.000285	0.00146	CcSEcCtD
Nabumetone—Headache—Temozolomide—brain cancer	0.000283	0.00145	CcSEcCtD
Nabumetone—Nausea—Carmustine—brain cancer	0.000278	0.00142	CcSEcCtD
Nabumetone—MPO—Folate Metabolism—RELA—brain cancer	0.000276	0.0117	CbGpPWpGaD
Nabumetone—PTGS2—central nervous system—brain cancer	0.000273	0.0136	CbGeAlD
Nabumetone—Nausea—Temozolomide—brain cancer	0.000269	0.00138	CcSEcCtD
Nabumetone—Hypersensitivity—Etoposide—brain cancer	0.000267	0.00136	CcSEcCtD
Nabumetone—PTGS2—cerebellum—brain cancer	0.000266	0.0132	CbGeAlD
Nabumetone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000265	0.0112	CbGpPWpGaD
Nabumetone—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000261	0.0111	CbGpPWpGaD
Nabumetone—Asthenia—Etoposide—brain cancer	0.00026	0.00133	CcSEcCtD
Nabumetone—Pruritus—Etoposide—brain cancer	0.000256	0.00131	CcSEcCtD
Nabumetone—PTGS1—Biological oxidations—CYP2C9—brain cancer	0.000254	0.0108	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—IL2—brain cancer	0.000249	0.0106	CbGpPWpGaD
Nabumetone—Diarrhoea—Etoposide—brain cancer	0.000248	0.00127	CcSEcCtD
Nabumetone—Dizziness—Etoposide—brain cancer	0.000239	0.00123	CcSEcCtD
Nabumetone—MPO—C-MYB transcription factor network—CDKN2A—brain cancer	0.000237	0.01	CbGpPWpGaD
Nabumetone—Vomiting—Etoposide—brain cancer	0.00023	0.00118	CcSEcCtD
Nabumetone—Rash—Etoposide—brain cancer	0.000228	0.00117	CcSEcCtD
Nabumetone—Dermatitis—Etoposide—brain cancer	0.000228	0.00117	CcSEcCtD
Nabumetone—Headache—Etoposide—brain cancer	0.000227	0.00116	CcSEcCtD
Nabumetone—PTGS1—brain—brain cancer	0.000226	0.0113	CbGeAlD
Nabumetone—MPO—Selenium Micronutrient Network—RELA—brain cancer	0.00022	0.00932	CbGpPWpGaD
Nabumetone—PTGS2—brain—brain cancer	0.000216	0.0108	CbGeAlD
Nabumetone—Nausea—Etoposide—brain cancer	0.000215	0.0011	CcSEcCtD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000215	0.0091	CbGpPWpGaD
Nabumetone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000214	0.00906	CbGpPWpGaD
Nabumetone—MPO—C-MYB transcription factor network—CCND1—brain cancer	0.0002	0.00849	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—GFAP—brain cancer	0.000199	0.00845	CbGpPWpGaD
Nabumetone—PTGS2—S1P1 pathway—VEGFA—brain cancer	0.000186	0.0079	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—CDK6—brain cancer	0.000175	0.0074	CbGpPWpGaD
Nabumetone—MPO—C-MYB transcription factor network—MYC—brain cancer	0.000161	0.00681	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—TP53—brain cancer	0.00016	0.00678	CbGpPWpGaD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—brain cancer	0.000156	0.00662	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—SOD2—brain cancer	0.000156	0.0066	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—brain cancer	0.000152	0.00647	CbGpPWpGaD
Nabumetone—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000141	0.00599	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—HES1—brain cancer	0.000128	0.00545	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—SOD2—brain cancer	0.000123	0.00524	CbGpPWpGaD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.00012	0.00509	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000118	0.00499	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000114	0.00484	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000112	0.00477	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000107	0.00454	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000102	0.00431	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—brain cancer	0.000101	0.00428	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	9.75e-05	0.00413	CbGpPWpGaD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	9.18e-05	0.00389	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	8.99e-05	0.00381	CbGpPWpGaD
Nabumetone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	8.63e-05	0.00366	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	8.57e-05	0.00363	CbGpPWpGaD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—MYC—brain cancer	8.44e-05	0.00358	CbGpPWpGaD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	8.26e-05	0.0035	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.74e-05	0.00328	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—CDKN2A—brain cancer	7.7e-05	0.00326	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—CDK4—brain cancer	7.67e-05	0.00325	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—RELA—brain cancer	7.14e-05	0.00303	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	7.13e-05	0.00302	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	7.04e-05	0.00298	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	6.9e-05	0.00293	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	6.82e-05	0.00289	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	6.78e-05	0.00288	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—CCND1—brain cancer	6.5e-05	0.00276	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	6.34e-05	0.00269	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	6.11e-05	0.00259	CbGpPWpGaD
Nabumetone—PTGS2—Disease—DTX2—brain cancer	6.09e-05	0.00258	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	6.04e-05	0.00256	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.66e-05	0.0024	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	5.22e-05	0.00221	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—MYC—brain cancer	5.22e-05	0.00221	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	5.19e-05	0.0022	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL2—brain cancer	5.08e-05	0.00216	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—CCND1—brain cancer	4.95e-05	0.0021	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—APC—brain cancer	4.91e-05	0.00208	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	4.78e-05	0.00203	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	4.67e-05	0.00198	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	4.67e-05	0.00198	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HES5—brain cancer	4.47e-05	0.0019	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.38e-05	0.00186	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP2C9—brain cancer	4.34e-05	0.00184	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—MYC—brain cancer	3.97e-05	0.00169	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—EGFR—brain cancer	3.89e-05	0.00165	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	3.81e-05	0.00162	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—BSG—brain cancer	3.69e-05	0.00157	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP2C9—brain cancer	3.45e-05	0.00146	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	3.37e-05	0.00143	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	3.34e-05	0.00142	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TP53—brain cancer	3.26e-05	0.00138	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.2e-05	0.00136	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—IDH1—brain cancer	3.17e-05	0.00135	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IDH1—brain cancer	3.01e-05	0.00128	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.94e-05	0.00125	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—BSG—brain cancer	2.93e-05	0.00124	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HEY1—brain cancer	2.85e-05	0.00121	CbGpPWpGaD
Nabumetone—PTGS2—Disease—DLL1—brain cancer	2.8e-05	0.00119	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.7e-05	0.00115	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.64e-05	0.00112	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.58e-05	0.0011	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—IDH1—brain cancer	2.52e-05	0.00107	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ENO2—brain cancer	2.51e-05	0.00106	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ENO2—brain cancer	2.38e-05	0.00101	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SHH—brain cancer	2.38e-05	0.00101	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.22e-05	0.000942	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.05e-05	0.00087	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ENO2—brain cancer	1.99e-05	0.000845	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP2C9—brain cancer	1.95e-05	0.000827	CbGpPWpGaD
Nabumetone—PTGS2—Disease—VAV1—brain cancer	1.72e-05	0.000729	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—BSG—brain cancer	1.66e-05	0.000703	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HES1—brain cancer	1.48e-05	0.000627	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—IDH1—brain cancer	1.43e-05	0.000605	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PDGFRA—brain cancer	1.41e-05	0.000597	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IRS2—brain cancer	1.24e-05	0.000524	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.16e-05	0.000492	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CG—brain cancer	1.15e-05	0.000488	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ENO2—brain cancer	1.13e-05	0.000478	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APC—brain cancer	1.09e-05	0.000463	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CG—brain cancer	9.14e-06	0.000388	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ERBB2—brain cancer	8.47e-06	0.000359	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CTNNB1—brain cancer	7.41e-06	0.000314	CbGpPWpGaD
Nabumetone—PTGS2—Disease—STAT3—brain cancer	6.46e-06	0.000274	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MYC—brain cancer	6e-06	0.000255	CbGpPWpGaD
Nabumetone—PTGS2—Disease—EGFR—brain cancer	5.87e-06	0.000249	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CG—brain cancer	5.17e-06	0.000219	CbGpPWpGaD
